Longevity Health Holdings (XAGE) Announces Fundraising Via ATM Sale

Longevity Health Holdings, Inc. (Nasdaq: XAGE) today announced the successful sale of 479,621 shares of its common stock at an average price of $4.08 per share through its at-the-market (ATM) equity offering facility. Gross proceeds from the ATM sales totaled approximately $1.96 million, prior to deducting fees and expenses.

Assuming no growth beyond the Company’s pro forma consolidated FY24 sales and not factoring in the planned 20/20 merger, this financing extends XAGE’s cash runway into Q1 FY26.

“We are pleased to strengthen our balance sheet further as we move forward with our planned merger with 20/20 and the continued delivery of innovative longevity products to our customers,” said Rajiv Shukla, Chairman and Chief Executive Officer of XAGE. “This successful ATM offering reflects continued investor confidence in our vision and growth strategy.”

You May Also Be Interested In

• ONE Nuclear Energy to trade on Nasdaq after SPAC merger closes
• SonicStrategy buys 500,000 SYN tokens for $115,000
• Park Dental Partners adds Arizona practice, now has 3 in state